EURONEXT Aktie

 

Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

Cambridge (UK) 13 May 2026 – Hybrid Software Group PLC (Euronext: HYSG) announces the result of its Annual General Meeting (“AGM”)....

PORTO, Portugal, May 12, 2026 /PRNewswire/ -- Sonae (Euronext Lisbon: SON), a Portuguese-based multinational managing a diversified portfolio of businesses across retail, real estate, telecommunications, technology and innovation, achieved record turnover of €11.4 billion in 2025, growing......

HILVERSUM, The Netherlands, May 11, 2026 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) announced today that its CFO, Matt Ellis, will participate in a question-and-answer session at the JP Morgan 2026 Global Technology, Media, and Communications Conference on Monday, May 18,......

HILVERSUM, The Netherlands, May 11, 2026 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) ("UMG" or "the Company") today announced that in the period from May 4, 2026 up to and including May 8, 2026 a total of 772,030 of its own shares were repurchased by the Company at an......

Euronext announces volumes for April 2026...

Sandnes, Norway, 8 May 2026: The annual general meeting of Vår Energi ASA (OSE: VAR) will be held on 29 May 2026 at 15:00 (CEST). The meeting will be held as a digital event. Shareholders can participate in the annual general meeting via webcast and also vote in advance or by proxy. The deadline for advance voting and proxy registration is 27 May 2026 at 15:00 CEST. Only shareholders registered in Euronext VPS as of 21 May 2026 are entitled to participate and vote. Please see further detailed information for registration and advance voting in the attached notice of the annual general...

Materialise transfers eyewear business to its management team Regulated information1LEUVEN, Belgium--(BUSINESS WIRE)--Materialise NV (Euronext & NASDAQ:MTLS), a global leader in 3D-printed medical devices and software, and a pioneer in additive manufacturing software and services, today announced its financial results for the first quarter ended March 31, 2026. Additionally, Materialise announced the transfer of its eyewear business to the eyewear management team. Highlights – First Quarter 2026 Total revenue was stable at 66,276 kEUR for the first quarter of 2026 compared to 66,379 kEUR for the corresponding 2025 period. Gross profit as a percentage of revenue for the first quarter of 2026 increased to 57.2%, compared to 55.3% for the corresponding 2025 period. Adjusted EBIT increased to 2,470 kEUR for the first quarter of 2026 from 646 kEUR for the first quarter of 2025. Net result for the first quarter of 2026 was 1,820 kEUR, or 0.03 EUR per diluted share, compared to a net loss of (535) kEUR, or (0....

May 6, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen Massey, Chief Executive Officer, will present at the BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 10:40 a.m. PT....

Galapagos' name change to Lakefront Biotherapeutics approved at the Company's EGM (Euronext & NASDAQ: LKFT)Collaboration Agreement with Gilead to advance potential First and Best-in-Class T Cell Engager expected to close in the Second Quarter of 2026Following this transaction, including estimated associated R&D spend until first approval, the Company will continue to have a majority of its current cash remaining for additional strategic transactions and other capital allocation prioritiesYear-end 2026 cash and financial investments balance expected to be approximately €2BManagement to host conference call on May 7, 2026, at 14:00 CET / 8:00 am ETMechelen, Belgium; May 6, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) today reported its financial results for the first quarter of 2026 and provided a business update.“Having joined the company just one year ago, I'm thrilled with our progress. I am looking forward to consummating our partnership with Gilead and addin...

HILVERSUM, The Netherlands, May 4, 2026 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) ("UMG" or "the Company") today announced that in the period from April 27, 2026 up to and including April 30, 2026 a total of 117,992 of its own shares were repurchased by the Company at an......

Sandvika 4 May 2026 (OSE: NORCO): The annual general meeting of Norconsult ASA was held today as a digital meeting with online participation. All proposals on the agenda were adopted. Minutes of the meeting are attached to this release and available on investor.norconsult.com. The general meeting approved distribution of a dividend of NOK 1.80 per share. The dividend is payable to shareholders holding shares in the company as per 4 May 2026. The shares will be traded ex-dividend on Euronext Oslo Stock Exchange from and including 5 May 2026. The dividend will be paid on or about 13 May...

LOS ANGELES, BOSTON & NEW YORK--(BUSINESS WIRE)--Two River, LLC (“Two River”) and Vida Ventures (“Vida”), both part of the Bellco Health ecosystem, today acknowledged the announced acquisition of Candid Therapeutics (“Candid”), a privately held clinical-stage biotechnology company redefining the treatment of autoimmune and inflammatory diseases through novel T-cell engagers (TCEs), by UCB (Euronext: UCB), a global biopharmaceutical company, for up to $2.2 billion, including $2.0 billion upfront. Two River and Vida played central roles in the creation and early development of Candid. Two River, together with Third Rock Ventures, helped found Candid, continuing Two River's consistent track record of founding and scaling innovative biotechnology companies as a leading incubator. Candid was formed through the merger of TRC 2004—founded by Two River—and Vignette Bio, bringing together complementary capabilities with an experienced management team to establish a leader in autoimmune TCE therapi...

April 30, 2026Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that it will host a conference call and audio webcast on Thursday, May 7, 2026 at 2:30 PM CET (8:30 AM ET) to discuss its first quarter 2026 financial results and provide a business update....

Tieto Corporation      STOCK EXCHANGE RELEASE      29 April 2026   6:30 p.m. EEST   Tieto (the “company”) announced on 8 April 2026 that it had filed an application for delisting of its shares from its secondary listing in Euronext Oslo Børs while remaining listed on Nasdaq Helsinki and Nasdaq Stockholm. Upon the application, the Euronext Oslo Børs has on 29 April 2026 decided that the shares in Tieto will be delisted as from 29 June 2026. The last day of trading on the Euronext Oslo Børs will 26 June 2026. The registration of the company's shares with the Norwegian securities...

PIRAEUS, Greece, April 29, 2026 (GLOBE NEWSWIRE) -- Navios Maritime Partners L.P. (“Navios Partners”) (NYSE: NMM), an international owner and operator of dry cargo and tanker vessels, announced today the approval of the listing application by Euronext Oslo Børs of Navios Partners' senior unsecured bond issue with an initial issue amount of USD 300,000,000, within a framework of USD 500,000,000, and with ISIN NO0013685115 on Euronext Oslo Børs. The bonds will commence trading on Euronext Oslo Børs today under the ticker code "NMM"....

Mechelen, Belgium; April 28, 2026, 22:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG) today announces that all resolutions proposed at the Company's Annual and Extraordinary Shareholders' Meetings (AGM and EGM) held on 28 April 2026 were approved....

HILVERSUM, The Netherlands, April 27, 2026 /PRNewswire/ -- Universal Music Group N.V. (EURONEXT: UMG) ("UMG" or "the Company") today announced that in the period from April 20, 2026 up to and including April 24, 2026 a total of 299,517 of its own shares were repurchased by the Company at......

Oslo, 27 April 2026 – Panoro Energy ASA (“Panoro” or the “Company” with OSE Ticker: PEN) today announces that the 2026 Annual General Meeting (“AGM”) will be held virtually through the facilities of Euronext on 21 May 2026 at 11:00am CEST (Norwegian time). It will not be possible to attend in person. The formal notice of the AGM is attached to this release and can also be downloaded from Panoro's website at www.panoroenergy.com. Important Information Pursuant to section 5-2 (1) of the Norwegian Public Limited Liability Act, only those who are shareholders five business days prior...